➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Dow
Colorcon
Johnson and Johnson
Harvard Business School

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LUBIPROSTONE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Lubiprostone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00380250 Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed Takeda Phase 3 2005-05-01 The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation.
NCT00380250 Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed Sucampo Pharmaceuticals, Inc. Phase 3 2005-05-01 The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation.
NCT00399542 Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation Completed Takeda Phase 3 2005-05-01 The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lubiprostone

Condition Name

Condition Name for Lubiprostone
Intervention Trials
Constipation 14
Chronic Idiopathic Constipation 7
Irritable Bowel Syndrome 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lubiprostone
Intervention Trials
Constipation 29
Irritable Bowel Syndrome 7
Syndrome 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lubiprostone

Trials by Country

Trials by Country for Lubiprostone
Location Trials
United States 342
United Kingdom 11
Canada 10
Mexico 8
Belgium 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lubiprostone
Location Trials
Texas 16
California 14
Alabama 14
Florida 14
Tennessee 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lubiprostone

Clinical Trial Phase

Clinical Trial Phase for Lubiprostone
Clinical Trial Phase Trials
Phase 4 11
Phase 3 19
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lubiprostone
Clinical Trial Phase Trials
Completed 30
Active, not recruiting 6
Recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lubiprostone

Sponsor Name

Sponsor Name for Lubiprostone
Sponsor Trials
Takeda 23
Takeda Pharmaceuticals North America, Inc. 10
Sucampo Pharmaceuticals, Inc. 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lubiprostone
Sponsor Trials
Industry 61
Other 25
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Boehringer Ingelheim
McKinsey
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.